Drug-Drug Interaction Study of ABP-671 in Gout Patients

NCT07367971 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Gout Chronic
Gout
DDI (Drug-Drug Interaction)

Interventions

DRUG: ABP-671 plus allopurinol

Sponsor

Atom Therapeutics Co., Ltd